Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators by Borgquist, Signe et al.
Open Access
Available online http://breast-cancer-research.com/content/9/1/R11
Page 1 of 11
(page number not for citation purposes)
Vol 9 No 1 Research article
Diet and body constitution in relation to subgroups of breast 
cancer defined by tumour grade, proliferation and key cell cycle 
regulators
Signe Borgquist1,2, Elisabet Wirfält3, Karin Jirström1, Lola Anagnostaki1, Bo Gullberg3, 
Göran Berglund3, Jonas Manjer4 and Göran Landberg1
1Division of Pathology, Department of Laboratory Medicine, Malmö University Hospital, S-205 02 Malmö, Sweden
2Division of Oncology, Department of Clinical Sciences, Lund University Hospital, S-221 85 Lund, Sweden
3Department of Clinical Sciences, Malmö University Hospital, S-205 02 Malmö, Sweden
4Department of Surgery, Malmö University Hospital, S-205 02 Malmö. Sweden
Corresponding author: Göran Landberg, goran.landberg@med.lu.se
Received: 21 Aug 2006 Revisions requested: 13 Oct 2006 Revisions received: 7 Jan 2007 Accepted: 25 Jan 2007 Published: 25 Jan 2007
Breast Cancer Research 2007, 9:R11 (doi:10.1186/bcr1644)
This article is online at: http://breast-cancer-research.com/content/9/1/R11
© 2007 Borgquist et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background The general lack of clear associations between
diet and breast cancer in epidemiological studies may partly be
explained by the fact that breast cancer is a heterogeneous
disease that may have disparate genetic associations and
different aetiological bases.
Method A total of 346 incident breast cancers in a prospective
cohort of 17,035 women enrolled in the Malmö Diet and Cancer
study (Sweden) were subcategorized according to conventional
pathology parameters, proliferation and expression of key cell
cycle regulators. Subcategories were compared with
prediagnostic diet and body measurements using analysis of
variance.
Results A large hip circumference and high body mass index
were associated with high grade tumours (P = 0.03 and 0.009,
respectively), whereas low energy and unadjusted fat intakes
were associated with high proliferation (P = 0.03 and 0.004,
respectively). Low intakes of saturated, monounsaturated and
polyunsaturated fatty acids were also associated with high
proliferation (P = 0.02, 0.004 and 0.003, respectively). Low
energy and unadjusted fat intakes were associated with cyclin
D1 overexpression (P = 0.02 and 0.007, respectively), whereas
cyclin E overexpression was positively correlated with fat intake.
Oestrogen receptor status and expression of the tumour
suppressor gene p27 were not associated with either diet or
body constitution.
Conclusion Low energy and low total fat (polyunsaturated fatty
acids in particular) intakes, and high body mass index were
associated with relatively more malignant breast tumours.
Dietary behaviours and body constitution may be associated
with specific types of breast cancer defined by conventional
pathology parameters and cyclin D1 and cyclin E expression.
Further studies including healthy control individuals are needed
to confirm our results.
Introduction
The aetiology of breast cancer is complex, but a number of risk
factors have been identified. In human studies body mass
index (BMI) and hip and waist circumferences have been
described as positively associated with risk for developing
breast cancer [1]. Animal experiments support these findings
and report that obesity enhances the development of mam-
mary tumours [2]. To our knowledge, no studies have been
conducted to evaluate whether there is an eventual associa-
tion between obesity and tumour characteristics in animals.
The association between dietary intake and body composition
is still under debate [3,4], and the biological link between diet
and breast cancer is unclear. Dietary studies indicate that diet
may contribute factors that either promote or protect against
breast cancer [5]. High alcohol intake, for example, has been
BMI = body mass index; ER = oestrogen receptor; MDCS = Malmö Diet and Cancer Study; MUFA = monounsaturated fatty acids; PUFA = polyun-
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associated with breast cancer [1,6]. A large number of studies
have examined the link between dietary fat and breast cancer,
and most studies have found no or weak associations [7-9]. A
recent attempt to clarify the hypothesis that a low-fat dietary
pattern can reduce breast risk was made by Prentice and cow-
orkers [10] in a randomized trial, but the results showed that
risk for breast cancer did not differ between the two groups
studied. The lack of any clear associations between diet and
breast cancer in epidemiological studies could result from dif-
ficulties in dietary assessment, but they may also result from
the fact that breast cancer is a heterogeneous disease that
may have disparate genetic associations and different aetio-
logical bases.
Breast cancer is heterogeneous in terms of pathology param-
eters such as tumour type, size, grade, hormone receptor sta-
tus and lymph node involvement. These subgroups are related
to clinical behaviours and prognoses [11]. Tumour prolifera-
tion, as reflected by the Ki67 index, is closely associated with
tumour aggressiveness, and the Ki67 index is often consid-
ered an independent prognostic marker for breast cancer
[12]. Another approach to defining subgroups of breast can-
cer is to map different gene aberrations in breast cancer. The
tumour suppressor gene p27 acts as a cyclin-dependent
kinase inhibitor [13]. Other gene aberrations related to defects
in cell cycle control such as overexpression of cyclin D1 or cyc-
lin E affect the cell cycle at the G1/S checkpoint and may
affect chromosomal stability [14,15]. Indeed, these aberra-
tions are common in cancer [16] and have even been pro-
posed to be mandatory in tumour transformation processes
[17]. In experimental animal studies [18] energy restriction
was found to reduce mammary tumour cell proliferation via G1
cell cycle arrest, establishing a connection between dietary
intake and cell cycle regulators.
The association between fat intake and breast cancer inci-
dence overall was studied in previous work as part of the
Malmö Diet and Cancer Study (MDCS), although with a
shorter follow-up period and fewer breast cancer cases [19].
The aim of the present study was to explore the association
between different subgroups of breast cancer and several die-
tary factors and body constitution. Incident breast cancer
cases from the MDCS were classified according to tumour
type, grade, oestrogen receptor (ER) status, expression of
p27, cyclin D1 and cyclin E, and proliferation (Ki67).
Materials and methods
Study population
The MDCS is a population-based prospective cohort study
[20]. Recruitment of the cohort was previously described in
detail [21]. Individuals joined the study either spontaneously or
after receiving an invitation by mail. Insufficient Swedish lan-
guage skills was the only exclusion criterion. A total of 17,035
women born between 1923 and 1950 took part in the study
and were examined during the period between 1991 and
1996.
Breast cancer cases were ascertained by record linkage with
the Swedish Cancer Registry, and by the end of the follow-up
cut-off date (31 December 2001) a total of 440 women had
been diagnosed with incident breast cancer. Ethics permis-
sion for the MDCS was obtained from the Ethical Committee
at Lund University (LU 51-90).
Dietary data
Diet history data were obtained by combining a 7-day menu
book ('current' diet information, concerning cooked meals and
cold beverages, as recorded by the participants at home) and
a diet history questionnaire ('usual' diet information, concern-
ing foods consumed regularly but not eaten during cooked
meals) in which the reference period was the preceding year.
Dietary interviewers conducted a 1-hour interview focusing on
food preparation and portion sizes, which were reported in the
7-day menu book, and checked the correctness of question-
naires that were completed at home. The reproducibility and
concurrent validity were examined using 18 days of weighed
food records collected over 1 year as the reference. Further
details are described elsewhere [22,23]. The period during
which the data were collected and by which dietary interviewer
were recorded. A dichotomized variable based on the ques-
tionnaire item 'Have you substantially changed your dietary
habits because of illness or any other reason?' was used to
identify any recent change in dietary habit. The coding routines
were altered halfway through the baseline examination period
in order to reduce the interview time; this resulted in two
method versions, referred to as the 'old' and 'new' versions
[19]. The nutrient variables examined in this study were daily
intake of total energy (J), total fat (g), protein (g), carbohydrate
(g), saturated fatty acids (SFA; g), monounsaturated fatty
acids (MUFA; g) and polyunsaturated fatty acids (PUFA; g).
Baseline examination
During the baseline examinations all participants completed a
dietary assessment and a lifestyle questionnaire, and had their
anthropometric measurement factors recorded.
At baseline, hip and waist circumferences (m) were measured
and BMI was calculated as kg/m2. Body composition was esti-
mated using a single frequency bioimpedance method (BIA
103; RLJ Systems, Detroit, MI, USA) to measure body fat per-
centage. Alcohol habits were defined, based on the question-
naire, in four categories: abstainers, low consumers, medium
consumers and high consumers. Smoking status was defined
as current, former, or never. A physical activity score was
obtained by multiplying the number of minutes used for each
activity, from a list of 18 activities modified from of the Minne-
sota Leisure Time Physical Activity Instrument [24] with an
activity-specific factor. Four categories of physical activityAvailable online http://breast-cancer-research.com/content/9/1/R11
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status were identified. These variables are described in detail
elsewhere [25].
Immunohistochemistry
Out of 440 women diagnosed with breast cancer, invasive
tumour material was obtained from 346 cases. In 38 cases
there was no available tissue. Fifty cases were diagnosed as
ductal carcinoma in situ and therefore excluded. Six cases
were biopsies only and not suitable for arraying. All cases were
re-evaluated by one breast pathologist (LA) and tumour grad-
ing was performed according to the method proposed by
Elston and Ellis [11]. For the construction of tissue microarays
(TMAs), two 0.6 mm tissue cores were collected from each
tumour block and arranged in a recipient block using a manual
tissue arrayer (Beecher Inc., Sun Prairie, WI, USA). Slides
were then processed in an automatic immunohistochemistry
staining machine. The antibodies used were as follows: ER
(pre-diluted anti-ER 6F11; Ventana, Tucson, AZ, USA), cyclin
D1 (1:100 DCS-6; Dako, Glostrup, Denmark), cyclin E (1:100
HE12; Santa Cruz, CA, USA), p27 kip1 (1:200 SX53G8;
Dako) and Ki67 (1:200 MIB-1; Dako). Tumours were grouped
into no, low, medium, or high expression of ER, cyclin D1, cyc-
lin E, p27 and Ki67, using the following respective cut-offs:
0% to 1%, 2% to 10%, 11% to 50% and 51% to 100% pos-
itive nuclei. To dichotomize the material, high and low catego-
ries were created for cyclin D1 and cyclin E (cut-off at 50%)
and Ki67 (cut-off at 10%). All arrays were evaluated independ-
ently twice (SB), and in case of discrepancy a third examina-
tion was performed followed by a final decision.
Statistical methods
All calculations were performed using SPSS version 11
(SPSS Institute, Chicago, IL, USA). Ln transformation of con-
tinuous variables (age, dietary intake and anthropometric fac-
tors) was carried out to normalize the data distribution. All
statistical tests were two-sided and a P value less than 0.05
was considered statistically significant. Correlation analysis
examined associations between pathology parameters. Analy-
sis of variance was used to compare means of dietary and
body measurements between different subgroups of breast
tumours. All analyses were adjusted for age at baseline. Anal-
yses concerning dietary intake were adjusted for diet assist-
ant, the period of data collection, diet methodology (old or new
method version) and recent food habit changes (yes or no), as
well as for total energy intake when stated. It has been sug-
gested that anthropometric factors may be associated in dif-
ferent directions with premenopausal and postmenopausal
breast cancer. Hence, we repeated all the analyses of anthro-
pometric factors separately for premenopausal and postmen-
opausal women.
Results
The distribution of breast tumours revealed a predominance of
ductal carcinomas (69%) as well as low-grade tumours (75%
grade 1 and 2). In the TMAs, adequate tumour material was
obtained in the majority of cases (91%), with a similar target-
ing rate for different tumour types (data not shown).
The distribution of demographic and breast cancer risk factors
in the study population is illustrated in Table 1. Correlations
between tumour type and grade as well as immunohistochem-
ical expression of ER, cyclin D1, cyclin E, p27 and Ki67 are
summarized in Table 2.
Anthropometric measurements in relation to subgroups 
of breast cancer
Small hip circumference, low BMI and tall stature before
breast cancer diagnosis were statistically significantly related
to low-grade tumours (Table 3). Height was negatively associ-
ated with overexpression of cyclin E. In the separate analyses
of premenopausal and postmenopausal women, a similar
trend was seen in both groups, although with a slightly ele-
vated P value for postmenopausal women and a nonsignificant
result in premenopausal women (data not shown). There were
no significant associations between objective body measure-
ments and ER, cyclin D1, p27 and Ki67 when analysing the
entire cohort. The separate analyses of premenopausal breast
cancer exhibited a statistically significant association between
high stature and tumours high in Ki67 and low in p27 (data not
shown). Body fat percentage was not significantly associated
with any specific subgroup of breast cancer.
Energy and macronutrients intake in relation to sub-
groups of breast cancer
Low energy intake was associated with nucleus grade 3
tumours as well as overexpression of cyclin D1 and high prolif-
eration (Table 4). Low fat intake was associated with high pro-
liferation and cyclin D1 overexpression, whereas high fat intake
was associated with overexpression of cyclin E. Following
adjustment for energy intake, the differences between sub-
groups were similar although less pronounced (Table 5).
Intake of carbohydrates or protein was not associated with any
subgroup of breast cancer.
Neither ER status nor the expression of the tumour suppressor
gene p27 was associated with any of the dietary variables.
Dietary fatty acids intake in relation to subgroups of 
breast cancer
Low intake of PUFA was associated with high proliferation
(Tables 4 and 5), and in energy-adjusted analyses the result
remained significant (data not shown; P = 0.04). Low intake of
MUFA was associated with overexpression of cyclin D1 and
high proliferation. Energy adjusted MUFA and proliferation
were associated, albeit with borderline significance. Low
intake of SFA was relatively more common in tumours of
nucleus grade 3 as well as in tumours of high proliferation and
with overexpression of cyclin D1, whereas overexpression of
cyclin E was associated with high SFA intake. The relation to
cyclin D1 remained significant with energy-adjusted SFA.Breast Cancer Research    Vol 9 No 1    Borgquist et al.
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Table 1
Description of the study population
Factor (number of individuals for whom information was available) Incident breast cancer (n = 440)
Age at baseline (years; 440) 57.2 (7.1)
Education (439) 70
O-level college 6
A-level college university 24
Type of occupation (431)
Manual worker 34
Nonmanual worker 59
Employer/self-employed 7
Married/cohabiting (440)
No 34
Yes 66
Age at menarche (years; 440)
≤12 22
>12 to <15 52
≥15 26
Parity (number of children; 426)
0 13
1 20
2 44
3 18
≥4 5
Age at first childbirth (years; 440)
Nullipara 13
≤20 17
>20 to ≤25 34
>25 to ≤30 26
>30 10
Menopausal status (440)
Premenopausal 25
Perimenopausal 7
Postmenopausal 68
Exposure to OC (439)
Never 49
Ever 51
Current use of HRT (440)
No 71
Yes 29
Body mass index (kg/m2; 440) 25.5 (4.1)
Alcohol consumption (440)
Nothing last year (teetotaller) 11
Something last year (not last month) 11
Something last month 78
Smoking (440)
Never 40
Current 30
Ex 30
Values are expressed as percentage or as mean (standard deviation). HRT, hormone replacement therapy; OC, oral contraceptives.Available online http://breast-cancer-research.com/content/9/1/R11
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Smoking status, alcohol habits and physical activity were not
associated with any specific subgroup of breast cancer (data
not shown).
Discussion
We found that low intakes of energy and total fat (especially
PUFA), and high BMI were associated with more malignant
breast cancer.
Some methodological issues must be addressed. Dietary
assessment may be biased because of measurement error, for
instance over- and under-reporting. The validity of dietary data
in the MDCS has been examined using 18 days of weighed
food records collected over 1 year in a subgroup of MDCS
participants (126 men and 115 women) and validity was found
to be high [22,23].
Whether energy-adjusted variables should be used when ana-
lyzing any relation between dietary intake and disease is a
matter of controversy among nutritional researchers [26,27],
and in this study we present results using the total, as well as
energy-adjusted, intake of macronutrients.
A prevalent or subclinical breast cancer may affect anthropo-
metric measurements and dietary habits. All data concerning
objective body measurements were gathered between 0.2
and 10.4 (mean 4.3) years before breast cancer diagnosis,
and the values were therefore most likely unaffected by dis-
ease. Supporting this interpretation is the lack of relation
between BMI and time to diagnosis (P = 0.526, r = -0.021
[Spearman's correlation test]). Similar results were obtained
for energy intake and time to diagnosis (P  = 0.208, r = -
0.060).
Tumour classification with regard to type and grade was per-
formed according to current classification systems. The tissue
microarray (TMA) technique used in this study is now a well
documented method for high-throughput tissue screening,
with two tissue cores considered a sufficient sampling amount
[28,29]. The distribution of the immunohistochemical markers
was in accordance with earlier studies [16], thus validating the
assessments.
The participation rate in the MDCS was about 40% of the
potential participant population. The participants did have a
higher incidence of breast cancer compared with the source
population [21] and were most likely a selected group in terms
of socioeconomic factors. Nevertheless, the distribution of his-
tological type and grade within the incident breast tumours in
this study was similar to that in other studies [11,30]. Even if
our breast cancer population were different from the back-
ground population, it would still be possible to make internal
comparisons between different tumour groups in terms of die-
tary and anthropometric measurements.
Because several methodological factors in the MDCS may
affect dietary measurements, all analyses were adjusted for
diet assistant, period of data collection, diet methodology and
past food habit change, as well as for total energy intake when
stated. Hence, these factors ought not to have confounded
dietary assessments. It was decided not to adjust the present
analysis for established risk factors for breast cancer or factors
that affect true dietary intake (for example socioeconomic
index), because the main objective was to conduct perform a
descriptive and exploratory analysis of dietary intake in differ-
ent groups of breast cancer as defined by pathological and
biological properties.
The present study includes a large number of comparisons,
and P values should be interpreted with caution. Because no
previous study has addressed the same issue using our meth-
odology, we consider the present analyses as a first, hypo-
thesis-generating study. Our findings need confirmation in
future studies including healthy control individuals.
Table 2
Associations between tumour type, grade, ER, cyclin D1, cyclin E, p27 and proliferation (Ki67)
Tumour
grading
Nucleus grade ER Cyclin D1 Cyclin E p27 Ki67
Tumour typea (<0.001**) (<0.001**) (0.01*) (0.11) (0.10) (0.67) (0.009**)
Tumour grading 1 (-) 0.789 (<0.001**) -0.374 (<0.001**) 0.082 (0.155) 0.339 (<0.001**) -0.271 (<0.001**) 0.530 (<0.001**)
Nucleus grade 1 (-) -0.369 (<0.001** 0.050 (0.391) 0.323 (<0.001**) -0.188 (0.001) 0.448 (<0.001**)
ER 1 (-) 0.154 (0.007**) -0.540 (<0.001**) 0.291 (<0.001**) -0.282 (<0.001**)
Cyclin D1 1 (-) 0.024 (0.674) 0.262 (<0.001**) 0.288 (<0.001**)
Cyclin E 1 (-) -0.094 (0.099) 0.395 (<0.001**)
p27 1 (-) -0.211 (<0.001**)
Ki67 1 (-)
P values are given in parentheses. aFor tumour type (ductal, lobular, tubular), the χ2 test was used. Otherwise, Pearson's correlation test was used. 
*P < 0.05, **P < 0.01. ER, oestrogen receptor.Breast Cancer Research    Vol 9 No 1    Borgquist et al.
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Table 3
Mean values for anthropometric measurements in specific subgroups of breast cancer
n Height (m) BMI (kg/m2) Hip (m) Waist (m) Body fat (%)
PAD
P value 0.98 0.69 0.19 0.16 0.82
D u c t a l 2 3 9 1 . 6 42 5 0 . 9 80 . 7 83 1
L o b u l a r 7 2 1 . 6 42 5 0 . 9 80 . 7 73 0
T u b u l a r 2 2 1 . 6 42 5 0 . 9 50 . 7 53 1
Othersa 1 3 -----
Grade
P value 0.01* 0.03* 0.009** 0.18 0.06
G r a d e  1 9 5 1 . 6 62 4 0 . 9 60 . 7 63 0
Grade 2 164 1.64 26 0.99 0.79 31
G r a d e  3 8 5 1 . 6 42 5 0 . 9 80 . 7 83 1
Nucleus grade
P value 0.08 0.11 0.02* 0.27 0.19
Nuclear grade 
1
52 1.65 24 0.95 0.76 30
Nuclear grade 
2
1 7 6 1 . 6 32 5 0 . 9 90 . 7 83 0
Nuclear grade 
3
1 1 5 1 . 6 32 6 0 . 9 80 . 7 83 1
ER
P value 0.62 0.33 0.14 0.41 0.39
0–1% 27 1.64 25 0.96 0.76 30
2–10% 4 1.63 27 1.02 0.78 32
11–50% 12 1.62 27 1.03 0.82 33
51–100% 277 1.64 25 0.98 0.78 30
Cyclin D1
P value 0.84 0.16 0.13 0.35 0.46
0–1% 208 1.64 25 0.98 0.78 30
2 – 1 0 % 6 4 1 . 6 42 6 0 . 9 90 . 7 93 1
11–50% 27 1.64 25 0.97 0.76 31
51–100% 12 1.63 24 0.93 0.74 30
Cyclin E
P value 0.002** 0.75 0.81 0.82 0.97
0–1% 251 165 25 0.98 0.78 30
2–10% 40 162 25 0.98 0.77 31
11–50% 16 161 26 0.98 0.79 31
51–100% 10 163 25 0.95 0.75 31
p27
P value 0.19 0.39 0.16 0.10 0.08
0–1% 90 165 25 0.98 0.78 31
2–10% 50 164 26 1.00 0.80 32
11–50% 71 163 25 0.96 0.76 30
51–100% 102 164 25 0.97 0.77 30
Ki67
P value 0.90 0.31 0.17 0.59 0.10
0–1% 130 164 25 0.97 0.77 30
2–10% 93 164 26 0.99 0.79 31
11–50% 57 165 25 0.97 0.77 30
51–100% 33 164 26 0.97 0.77 31
aMucinous, medullary, and intracystic breast tumours were not included in statistical analyses because of their small number. *P < 0.05; **P < 
0.01. ER, oestrogen receptor; PAD, pathological anatomical diagnosis.Available online http://breast-cancer-research.com/content/9/1/R11
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Table 4
Means of intake of energy, macronutrients, and fatty acids in relation to specific subgroups of breast cancer
Energy 
(Joule/day)
Total fat (g/
day)
Total 
carbohydrate
s (g/day)
Total protein 
(g/day)
Total alcohol 
(g/day)
SFA (g/day) MUFA (g/
day)
PUFA (g/day)
PAD
P value 0.82 0.56 0.84 0.94 0.12 0.86 0.34 0.27
Ductal 1955 82 212 76 1.0 35 29 13
Lobular 1929 79 210 75 1.9 34 27 12
Tubular 2006 82 219 77 2.6 34 28 13
Othersa
Grade
P value 0.09 0.20 0.39 0.02* 0.28 0.16 0.34 0.40
1 2002 83 216 78 1.7 35 29 13
2 1966 82 212 77 1.3 35 29 13
3 1852 77 204 71 0.9 32 27 12
Nucleus grade
P value 0.02* 0.07 0.06 0.02* 0.10 0.04* 0.16 0.48
1 2012 83 217 78 2.5 36 29 13
2 2002 84 217 78 1.1 36 29 13
3 1846 77 201 72 1.0 32 27 12
ER
P value 0.90 0.75 0.77 0.80 0.80 0.73 0.55 0.98
0 1955 81 219 72 0.9 33 29 13
1 1794 74 188 76 3.7 31 25 12
2 1895 75 214 77 1.3 31 25 13
3 1954 82 211 76 1.3 35 29 13
Cyclin D1
P value 0.11 0.06 0.37 0.12 0.56 0.02* 0.046* 0.47
0 1968 82 213 77 1.3 35 29 13
1 1943 82 208 74 1.4 34 29 13
2 1891 80 206 71 0.6 36 28 12
3 1651 64 185 67 0.6 25 22 11
Cyclin E
P value 0.10 0.03* 0.43 0.25 0.40 0.04* 0.05 0.14
0 1963 82 212 76 1.4 35 29 13
1 1786 72 198 71 0.6 30 26 12
2 2016 83 222 79 1.6 34 30 13
3 2139 98 222 81 1.0 42 34 16
p27
P value 0.49 0.93 0.12 0.43 0.78 0.98 0.96 0.69
0 1970 81 216 75 1.3 34 29 13
1 1947 81 217 75 0.8 34 28 13
2 1876 80 197 73 1.3 34 28 12
3 1988 83 214 78 1.3 35 29 13
Ki67
P value 0.16 0.02* 0.78 0.40 0.27 0.02* 0.02* 0.02*
0 1970 83 210 77 1.6 35 29 13
1 2002 85 214 77 1.4 36 30 13
2 1835 72 206 72 0.7 30 25 12
3 1872 79 204 73 0.8 35 28 11
aMucinous, medullary and intracystic breast tumours were not included in statistical analyses because of their small number. *P < 0.05; **P < 
0.01. ER, oestrogen receptor; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; PAD, pathological anatomical diagnosis; 
SFA, saturated fatty acids.Breast Cancer Research    Vol 9 No 1    Borgquist et al.
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In this report we demonstrate an association between highly
proliferative tumours and low energy intake, as well as low
intakes of fat and PUFA. Several other human studies have
reported that high energy intake is related to increased risk for
breast cancer [31,32], but it is still unclear whether fat has a
specific impact on breast cancer risk [7,9]. To our knowledge,
no studies have reported on any association between diet and
proliferation in breast cancer.
Furthermore, we found an association between low energy
intake, particularly low fat intake, and overexpression of cyclin
D1. Cyclin E, however, was positively associated with fat
intake, but this association did not remain significant in the
dichotomized analyses. The opposite behaviours for cyclin D1
and cyclin E are in accordance with earlier observations show-
ing that cyclin E overexpressing tumours are low in cyclin D1
and vice versa [33]. Experimental animal studies support our
findings of a connection between dietary intake and cell cycle
regulators because energy restriction has been demonstrated
to reduce mammary tumour cell proliferation via G1 cell cycle
arrest, possibly through increased expression of p27 and
reduced expression of cyclin D1 [18,34]. This may appear to
be in conflict with our results, in which low energy intake was
associated with cyclin D1 overexpression, and p27 did not
exhibit any connection to energy intake. However, animal mod-
els using chemically induced breast tumours cannot readily be
translated into a far more complex tumour genesis in humans,
which presumably are influenced by a multitude of environ-
mental factors.
Subgroups defined by ER were not linked to dietary behaviour
or body composition. Some studies indicate that high fat diets
are associated with increased risk for ER-positive tumours
[35-37], whereas Verreault and coworkers [38] found no
association between dietary fat and ER status. A few studies
suggest that different types of PUFA may have opposing influ-
ences on breast cancer risk [39,40]. Studies concerning body
constitution report an increased risk for ER-positive tumours in
obese postmenopausal women who are supplied with oestro-
gens via conversion of androstendione to oesterone in fat tis-
sues, which is in contrast to premenopausal women, whose
primarily oestrogen source is the ovaries [41]. However, the
present analyses include both premenopausal and postmeno-
pausal women because there are only a limited number of
cases in each subgroup, making further stratification into pre-
menopausal and postmenopausal women unsuitable. This
might explain the different results. Furthermore, analyses in the
present study did not include healthy control individuals, which
might also have contributed to the different results. However,
in order to map potential differences in anthropometric risk
factors in premenopausal and postmenopausal breast cancer,
we performed separate analyses, which confirmed our initial
results in the entire cohort. In addition, premenopausal breast
tumours were characterized by high proliferation and low
expression of p27 in tall women. The suppressor gene product
p27 was not associated with any examined variable in the
entire cohort. Few comparable human studies have addressed
the relationship between p27 and dietary habits or body
constitution; Daling and coworkers [42] examined the relation-
Table 5
Means of intake of energy, macronutrients, and fatty acids in relation to specific subgroups of breast cancer
Energy 
(Joules/day)
Total fat
(g/day)
Energy-
adjusted fat 
(g/day)
SFA (g/day) Energy-
adjusted 
SFA (g/day)
MUFA
(g/day)
Energy-
adjusted 
MUFA
(g/day)
PUFA
(g/day)
Energy-
adjusted 
PUFA
(g/day)
Cyclin D1
a
P value 0.02* 0.007** 0.16 0.002* 0.04* 0.006** 0.13 0.32 0.31
Low 1957 82 81 35 34 29 28 13 13
High 1652 63 76 25 30 22 26 11 13
Cyclin Eb
P v a l u e 0 . 2 60 . 0 70 . 0 90 . 0 90 . 1 80 . 0 80 . 1 20 . 0 70 . 1 5
Low 1937 80 81 34 34 28 28 13 13
High 2123 97 88 42 38 34 31 15 14
Ki67c
P value 0.029* 0.004** 0.048* 0.019* 0.315 0.004** 0.058 0.003** 0.053
Low 1984 84 82 35 35 29 29 13 13
High 1850 75 79 32 34 26 28 12 12
All analyses are adjusted for age, diet assistant, period, method version and changed dietary habits. Energy adjustment is applied where stated. 
aCyclin D1 overexpression with nucleus fraction ≥50%. bCyclin E overexpression with nucleus fraction ≥50%. cHigh proliferation index with nuclear 
fraction ≥10. *P < 0.05; **P < 0.01. MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids.Available online http://breast-cancer-research.com/content/9/1/R11
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ship between BMI and p27 but found no significant
associations.
In contrast to fat, protein and carbohydrate were not signifi-
cantly associated with any specific tumour characteristics. A
recently published report [43] indicates an association
between increased intake of carbohydrates and breast can-
cers with more favourable prognosis, which is consistent with
the nonsignificant tendency observed in the present study.
The tumour-promoting effects of fat may be dependent on
amount as well as type [44]. In the present study, the inverse
relation between energy-adjusted PUFA and proliferation was
most pronounced, indicating that low intake of PUFA corre-
sponds with the occurrence of highly proliferative breast can-
cer. A previous study from the MDCS including 237 incident
breast cancer cases found a positive association between
high intake of PUFA, specifically ω 6 fatty acids, and breast
cancer incidence [19]. Other studies analyzing the risk for
breast cancer have indicated similar positive associations
between PUFA and breast cancer incidence [19,45]. Human
studies on the association between fatty acids and breast
tumour characteristics have, to our knowledge, not yet been
published, and further studies are needed in order to validate
our preliminary findings.
Body composition, expressed in terms of BMI, waist and hip
circumference, and height, was associated with tumour grade,
and slender body constitution corresponded with low-grade
tumours. The association between body constitution and
breast cancer stage has been reported in other studies
[46,47], and an association between obesity and high-grade
tumours has also been described [42]. These observations
support our findings.
In the present study body size and distribution of body fat were
clearly associated with histological grade, whereas energy
intake – with an emphasis on fat – appeared to influence the
proliferation rate and overexpression of cell cycle regulators.
The image of a slender figure with high energy and fat intake
and a correspondence with a less malignant phenotype may
seem controversial. However, similar to other epidemiological
studies [3,48], energy and fat intake and body constitution
were shown not to be significantly associated (data not
shown). Notably, the variable 'total energy' should not be con-
fused with 'energy balance', which takes energy expenditure
into account [49]. This might explain why, in this study, high
energy intake and a slender figure are both related to less
aggressive tumours. Physical activity was nevertheless not
associated with any specific subgroup of breast cancer, which
could be caused by difficulties in assessing this variable [50].
Obese individuals commonly report low-energy diets [51] as
well as recent changes in dietary habits [52], making it plausi-
ble that obese participants are in reality low in energy intake.
Alcohol intake was not associated with any of the breast can-
cer subgroups examined, but a previous report from the
MDCS identified an association between high intake of wine
or total alcohol (nonsignificant) and increased breast cancer
risk [6].
Conclusion
The above findings indicate that the strategy of subgrouping
breast cancer according to proliferation, tumour grade and
expression of cyclin D1 and E might be a useful approach
when studying breast cancer in relation to dietary behaviours
and body constitution. Further studies are needed to improve
the delineation of women at risk for developing highly malig-
nant breast cancer and, hopefully, to contribute to novel pre-
vention strategies.
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